Related Experiment Video
Updated: Jan 9, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Job Loss after Cancer Diagnosis among Working-Age Cancer Survivors
Ryuya Yamamoto1,2, Yoko M Nakao1,3, Satomi Yoshida1,4
1Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan.
Background:
Cancer survivors have a higher risk of job loss than individuals in the general population. We aimed to investigate the employment status of cancer survivors in Japan.
Methods:
In this retrospective cohort study, we analyzed data from the JMDC, Inc. from January 2007 to September 2023 (diagnosis period). Individuals aged 18 to 55 years with cancer diagnoses and undergoing treatment and a control group without cancer, heart disease, stroke, or mental disorders were included. The primary outcome was comparative job loss cumulative incidence between groups. As a secondary outcome, we evaluated factors associated with job loss for all cancer survivors. Cox proportional hazards models were used for analysis.
Results:
This study included 112,964 cancer survivors (average age, 41.3 years; SD 9.08); 51.5% were women. Job loss cumulative incidence among cancer survivors 5 years after a cancer diagnosis was 76.2%, and the HR (95% confidence interval) was significantly higher than that in the control group (1.40; 1.38-1.41). In all cancer survivors, HRs were higher for men (1.64; 1.62-1.67) and those aged >50 years (1.61; 1.58-1.65). Job loss-related factors for all cancer survivors included female sex; brain tumors, pancreatic, skin, or female genital cancers; and ongoing chemotherapy and radiotherapy.
Conclusions:
Cancer survivors had higher job loss risks than the controls at 1 and 5 years after diagnosis. Being female and having specific types of cancers may be job loss-related factors.
Impact:
Cancer survivors face a high risk of job loss; thus, support for continued employment should reflect treatment conditions.
Related Concept Videos
Cancer Survival Analysis
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

